Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Results entities : Novo nordisk a::S save search
Ventus Therapeutics Announces Results from Phase 1 Clinical Trial of VENT-02, a Novel, Orally Administered, Brain-Penetrant NLRP3 Inhibitor
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.22%
H: 0.21%
C: -0.34%
vent-02 trial therapeutics results
Zealand Pharma Announces Financial Results for the First Half of 2023
Published: 2023-08-17 (Crawled : 05:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.61%
H: 0.79%
C: -0.57%
pharma financial results
Zealand Pharma Announces Financial Results for the First Quarter of 2023
Published: 2023-05-11 (Crawled : 05:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.19%
H: 0.25%
C: -0.44%
pharma financial results
Innate Pharma to Present Results From a Preliminary Analysis of the TELLOMAK Phase 2 Trial in Patients With Advanced Sezary Syndrome and ANKET™ Platform at ASH 2022
Published: 2022-11-04 (Crawled : 10:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.02%
H: 0.43%
C: 0.43%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.25%
H: 0.11%
C: -1.03%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 2.05%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -4.27%
H: 8.9%
C: 6.93%
pharma trial results platform
Innate Pharma 2023 Financial Calendar Innate Pharma SA released its 2023 financial calendar. argenx to Report Third Quarter 2022 Financial Results and Business Update on October 27, 2022 argenx announc...
Published: 2022-10-20 (Crawled : 07:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.35%
H: 1.28%
C: -0.17%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.19%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.0%
H: 2.4%
C: 1.92%
DNLI | $15.98 -3.74% -3.88% 1.5M
|
Health Technology
|
| O: -5.24%
H: 10.87%
C: 5.45%
pharma report financial update results
Innate Pharma Reports First Half 2022 Financial Results and Business Update
Published: 2022-09-15 (Crawled : 06:00) - biospace.com/
BNPQF | $68.558 -13.4% 400
|
Finance
|
| O: -1.65%
H: 0.0%
C: -2.85%
BNPQY | $34.61 -2.68% 100K
|
Finance and Insurance
|
| O: -1.12%
H: 2.34%
C: 1.69%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: -6.5%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.88%
H: 0.45%
C: -0.87%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.4%
H: 0.84%
C: 0.37%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 3.25%
H: 0.0%
C: 0.0%
pharma financial update results
Innate Pharma Reports First Quarter 2022 Financial Results and Business Update
Published: 2022-05-10 (Crawled : 07:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -0.37%
H: 2.23%
C: 0.93%
pharma results
Innate Pharma Reports Full Year 2021 Financial Results and Business Update
Published: 2022-03-24 (Crawled : 08:00) - biospace.com/
BNPQY | $34.61 -2.68% 100K
|
Finance and Insurance
|
| O: -0.98%
H: 1.17%
C: 0.78%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.27%
H: 0.98%
C: 0.93%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -3.17%
results pharma
Innate Pharma Announces Conference Call and Webcast for Full Year 2021 Financial Results
Published: 2022-03-17 (Crawled : 07:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.62%
H: 0.0%
C: 0.0%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 2.33%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.17%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 1.51%
H: 2.38%
C: 2.08%
financial results conference results pharma
Dicerna Announces Third Quarter 2021 Financial Results and Provides a Business Update
Published: 2021-11-09 (Crawled : 13:15) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.41%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.59%
H: 0.0%
C: 0.0%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 0.44%
H: 0.0%
C: -2.69%
financial results results
Dicerna Announces Results for PHYOX™4, Single-Dose Study of Nedosiran in Primary Hyperoxaluria Type 3 (PH3)
Published: 2021-10-19 (Crawled : 12:15) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.08%
H: 1.66%
C: 1.26%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.03%
H: 1.46%
C: 1.36%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -0.16%
H: 1.75%
C: 1.48%
results
Innate Pharma Reports First Half 2021 Financial Results and Business Update
Published: 2021-09-15 (Crawled : 06:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.32%
H: 0.05%
C: -0.08%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: -0.55%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 11.15%
H: 0.48%
C: -8.22%
financial results results pharma
Dicerna Announces Second Quarter 2021 Financial Results and Provides a Business Update
Published: 2021-08-09 (Crawled : 12:15) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.64%
H: 0.89%
C: 0.58%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.33%
H: 3.2%
C: 0.98%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 0.37%
H: 4.18%
C: 3.46%
financial results results
Dicerna Reports Positive Top-Line Results From PHYOX™2 Pivotal Clinical Trial of Nedosiran for the Treatment of Primary Hyperoxaluria
Published: 2021-08-05 (Crawled : 21:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 3.16%
H: 1.88%
C: 1.77%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.31%
H: 0.85%
C: 0.35%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 0.2%
H: 5.7%
C: 5.5%
treatment positive results trial topline
Dicerna to Report Second Quarter 2021 Financial Results on Aug. 9, 2021
Published: 2021-08-02 (Crawled : 22:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.44%
H: 0.89%
C: 0.88%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.43%
H: 0.88%
C: 0.35%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -1.81%
H: 0.94%
C: -0.19%
financial results results
Alliance Trust PLC - Half Year Results
Published: 2021-07-23 (Crawled : 07:00) - globenewswire.com
TGT | $168.3 1.03% 0.0% 3.3M
|
Retail Trade
|
| O: 0.3%
H: 1.29%
C: 1.26%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.58%
H: 0.0%
C: 0.0%
NOK | News | $3.52 2.03% 0.0% 17M
|
Electronic Technology
|
| O: 0.52%
H: 0.52%
C: -0.52%
MSCI | $510.07 0.85% 0.0% 520K
|
Technology Services
|
| O: 0.22%
H: 1.16%
C: 0.96%
FLT 4 | $305.8 -0.83% 350K
|
Commercial Services
|
| O: 0.91%
H: 1.35%
C: 0.22%
XOM | News | $119.88 1.15% -0.01% 21M
|
Energy Minerals
|
| O: -0.32%
H: 0.0%
C: 0.0%
NVDA | $762.01 -10.0% -10.37% 87M
|
Electronic Technology
|
| O: 0.32%
H: 0.22%
C: -0.5%
MSFT | News F | $399.09 -1.28% -1.3% 29M
|
Technology Services
|
| O: 0.43%
H: 0.91%
C: 0.8%
BIDU | $95.025 -0.58% -0.58% 1.8M
|
Technology Services
|
| O: -3.27%
H: 0.5%
C: 0.01%
AMZN | $174.63 -2.56% -2.63% 54M
|
Retail Trade
|
| O: 0.05%
H: 0.72%
C: 0.46%
results
Dicerna Announces Interim Results From Phase 1 Trial of Belcesiran for Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
Published: 2021-07-21 (Crawled : 13:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.9%
H: 0.72%
C: 0.58%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.58%
H: 0.42%
C: 0.38%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 0.45%
H: 0.0%
C: -2.13%
disease liver disease treatment phase 1 results liver trial phase 2 phase 3
Innate Pharma reports Full Year 2020 financial results and business update
Published: 2021-03-18 (Crawled : 07:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.43%
H: 0.99%
C: 0.23%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.45%
H: 0.7%
C: 0.43%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -4.27%
H: 1.16%
C: 1.16%
financial results results pharma
Innate Pharma Reports Full Year 2020 Financial(1) Results and Business Update
Published: 2021-03-18 (Crawled : 07:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.43%
H: 0.99%
C: 0.23%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.45%
H: 0.7%
C: 0.43%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -4.27%
H: 1.16%
C: 1.16%
results pharma
Innate Pharma announces conference call and webcast for Full Year 2020 financial results
Published: 2021-03-16 (Crawled : 06:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.0%
H: 0.96%
C: 0.78%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.27%
H: 1.17%
C: 1.15%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.0%
H: 1.06%
C: 0.85%
financial results results conference pharma